Green Alpha Advisors, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1439207 NIWOT, CO

Position in RXRX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$541,486

+$74,546 QoQ

Shares Held

147,544

-3.0% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#102

of 340 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Green Alpha Advisors, LLC holds $9,323,372 across 14 Biotechnology names. RXRX ranks #5 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	55,804	$3,043,550
2	MRNA	Moderna, Inc.	33,758	$2,364,072
3	PRME	Prime Medicine, Inc.	185,023	$682,734
4	CRBU	Caribou Biosciences, Inc.	364,324	$641,210
5	RXRX	Recursion Pharmaceuticals, Inc. This page	147,544	$541,486
6	EDIT	Editas Medicine, Inc.	156,046	$505,589
7	VRTX	Vertex Pharmaceuticals Inc / Ma	552	$274,194
8	BEAM	Beam Therapeutics Inc.	7,569	$259,768

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$541,486	147,544	-3.0%	Shares	Sole	2026-08-11
2026-03-31	$466,940	152,098	+0.7%	Shares	Sole	2026-04-07
2025-12-31	$617,909	151,078	-28.8%	Shares	Sole	2026-01-07
2025-09-30	$1,035,545	212,202	+21.2%	Shares	Sole	2025-10-15
2025-06-30	$885,970	175,093	-2.1%	Shares	Sole	2025-08-01
2025-03-31	$946,238	178,873	+166.4%	Shares	Sole	2025-04-09
2024-12-31	$453,900	67,145	+3.6%	Shares	Sole	2025-01-13
2024-09-30	$427,025	64,799	+2.9%	Shares	Sole	2024-10-07
2024-06-30	$472,492	62,999	-13.0%	Shares	Sole	2024-08-13
2024-03-31	$722,166	72,434	+6.7%	Shares	Sole	2024-04-10
2023-12-31	$669,208	67,871	+96.5%	Shares	Sole	2024-01-05
2023-09-30	$264,246	34,542	—	Shares	Sole	2023-10-10
No filing history on record for this holder in this stock.